How Much Is Mokslo tyrimų ir inovacijų klinika, UAB Worth?
Mokslo tyrimų ir inovacijų klinika, UAB - Company Valuation
Combines filings, registry risk signals, and versioned market evidence. Learn More ↗ Opens in a New Tab
Enterprise Value
1,524,711 €
- Range
- 1,063,801 €–2,735,110 €
- Evidence StrengthShows how strongly available evidence supports the result. Learn More ↗ Opens in a New Tab
- Low
- Based on FY
- 2025
- Valuation Date
- Business StrengthSummarises business strength from financial and public-record signals. Learn More ↗ Opens in a New Tab
- C+
- Risks
- Insufficient Data
Scope & Evidence
- Company
- Mokslo tyrimų ir inovacijų klinika, UAB
- Registration
- LT · 305839607
- Covers
- Single Company
- Filings Used
- 5 · FY 2025, 2024, 2023, 2022, 2021
Industry: NACE 72 · 3 Emerging Markets industry cohorts
Methodology & Assumptions
- Industry EV / EBITDA
- 25.4×
- Industry Revenue Multiple
- 8.30×
- Revenue Multiple
- 8.30×
- Enterprise Value
- 1,524,711 €
- Value Before Discount
- 1,524,711 €
Key Ratios
- Current RatioCurrent assets divided by current liabilities. Learn More ↗ Opens in a New Tab
- -
- Quick RatioCurrent assets minus inventory, divided by current liabilities. Learn More ↗ Opens in a New Tab
- -
- Debt / EquityTotal liabilities divided by equity. Learn More ↗ Opens in a New Tab
- 0.71×
- Equity RatioEquity as a share of total assets. Learn More ↗ Opens in a New Tab
- -
- Interest CoverageEBIT divided by interest expense. Learn More ↗ Opens in a New Tab
- -
- Gross MarginGross profit as a share of revenue. Learn More ↗ Opens in a New Tab
- -
- Net Profit MarginNet profit as a share of revenue. Learn More ↗ Opens in a New Tab
- 1.2%
- Return on EquityNet profit as a share of owners' equity. Learn More ↗ Opens in a New Tab
- 3.1%
- Return on AssetsNet profit as a share of total assets. Learn More ↗ Opens in a New Tab
- -
- Revenue CAGRAverage annual revenue growth over the available period. Learn More ↗ Opens in a New Tab
- 63.8%
3-Year Revenue Scenarios
600k €
450k €
300k €
150k €
0 €
202620272028
OptimisticBaseConservative
A comparison between a company and a defined peer group. Learn More ↗ Opens in a New Tab
Revenue vs Industry Peers
- UAB Biotechnologinės farmacijos centras "Biotechpharma"
- 74,035,286 €
- UAB "Altus Technicus"
- 35,859,341 €
- Mokslo tyrimų ir inovacijų klinika, UAB ★
- 213,135 €
- MB "Komplimeda"
- 18,385 €
- MB Technostartas
- 4,938 €
Earnings before interest, taxes, depreciation, and amortisation. Learn More ↗ Opens in a New Tab
Revenue, Profit & EBITDA
220k €
165k €
110k €
55k €
0 €
20212022202320242025
RevenueNet Profit
Versus Industry Median
220k €
165k €
110k €
55k €
0 €
RevenueNet Profit
This CompanyIndustry Median